Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for treating acute myeloid leukemia, containing FLT3 inhibitor and chemotherapeutic agents

Pharmaceutical composition for treating acute myeloid leukemia, containing FLT3 inhibitor and chemotherapeutic agents

US Patent 12350265 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyridine derivative compounds and use of same2025
Imidazopyridine derivative compounds and use of same2025
Pharmaceutical composition comprising FLT3 inhibitor and hypomethylating agent f2025
Protein complex comprising non-peptidyl polymer-coupled fatty acid derivative co2025
Heterotricyclic derivative compound and use of same2025
Pyrimidine compounds and pharmaceutical compositions for preventing or treating 2025
Pyrimidine compounds and pharmaceutical compositions for preventing or treating 2025
Pyrimidine compounds and pharmaceutical compositions for preventing or treating 2025
System and method for measuring load of vehicle using optimal resonant frequency2025
Salts of 4-amino-N-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)2023
Dioxoloisoquinolinone derivatives and use thereof2022
Thieno[3,2-d]pyrimidine derivative compound having inhibitory activity for prote2022